Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Aberg

Showing results (371-380 of 424) with videos related to

Pageof 43
Sort By:
JCI Insight|February 22, 2023
Effect of host factors and COVID-19 infection on the humoral immune repertoire in treated HIVSamuel R Schnittman, Wonyeong Jung, Kathleen V Fitch, et al.
Frontiers in Immunology|March 27, 2023
Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiativeHector Bonilla, Michael J Peluso, Kathleen Rodgers, et al.
Journal of the American Heart Association|December 11, 2025
Baseline ECG and Cardiovascular Outcomes in People With HIV: Insights From REPRIEVEAya Awwad, Christopher de Filippi, Heather Ribaudo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 15, 2022
Geographical Differences in the Self-Reported Functional Impairment of People With Human Immunodeficiency Virus (HIV) and Associations With Cardiometabolic RiskKristine M Erlandson, Kathleen V Fitch, Sara A McCallum, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 17, 2022
Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV)Samuel R Schnittman, Michael T Lu, Thomas Mayrhofer, et al.
AIDS (London, England)|May 27, 2025
Risks for sudden cardiac and undetermined cause of death among people with HIV in the REPRIEVE primary cardiovascular prevention trialChristopher deFilippi, Aya Awwad, Gerald S Bloomfield, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 5, 2024
Cytomegalovirus IgG is Associated With Physical Function But Not Muscle Density in People With HIVMaheen Z Abidi, Triin Umbleja, Edgar T Overton, et al.
Alcoholism, Clinical and Experimental Research|February 15, 2017
Deep Sequencing of 71 Candidate Genes to Characterize Variation Associated with Alcohol DependenceShaunna L Clark, Joseph L McClay, Daniel E Adkins, et al.
Open Forum Infectious Diseases|June 16, 2025
Prognostic Factors of Physical Function Decline Among Middle-Aged Adults With HIVGrace L Kulik, Triin Umbleja, Todd T Brown, et al.
Open Forum Infectious Diseases|March 31, 2023
Coronary Artery Plaque Composition and Severity Relate to the Inflammasome in People With Treated Human Immunodeficiency VirusSamuel R Schnittman, Douglas W Kitch, Talia H Swartz, et al.
Pageof 43

Showing results (371-380 of 424) with videos related to

Sort By:
Pageof 43
JCI Insight|February 22, 2023
Effect of host factors and COVID-19 infection on the humoral immune repertoire in treated HIVSamuel R Schnittman, Wonyeong Jung, Kathleen V Fitch, et al.
Frontiers in Immunology|March 27, 2023
Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiativeHector Bonilla, Michael J Peluso, Kathleen Rodgers, et al.
Journal of the American Heart Association|December 11, 2025
Baseline ECG and Cardiovascular Outcomes in People With HIV: Insights From REPRIEVEAya Awwad, Christopher de Filippi, Heather Ribaudo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 15, 2022
Geographical Differences in the Self-Reported Functional Impairment of People With Human Immunodeficiency Virus (HIV) and Associations With Cardiometabolic RiskKristine M Erlandson, Kathleen V Fitch, Sara A McCallum, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 17, 2022
Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV)Samuel R Schnittman, Michael T Lu, Thomas Mayrhofer, et al.
AIDS (London, England)|May 27, 2025
Risks for sudden cardiac and undetermined cause of death among people with HIV in the REPRIEVE primary cardiovascular prevention trialChristopher deFilippi, Aya Awwad, Gerald S Bloomfield, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 5, 2024
Cytomegalovirus IgG is Associated With Physical Function But Not Muscle Density in People With HIVMaheen Z Abidi, Triin Umbleja, Edgar T Overton, et al.
Alcoholism, Clinical and Experimental Research|February 15, 2017
Deep Sequencing of 71 Candidate Genes to Characterize Variation Associated with Alcohol DependenceShaunna L Clark, Joseph L McClay, Daniel E Adkins, et al.
Open Forum Infectious Diseases|June 16, 2025
Prognostic Factors of Physical Function Decline Among Middle-Aged Adults With HIVGrace L Kulik, Triin Umbleja, Todd T Brown, et al.
Open Forum Infectious Diseases|March 31, 2023
Coronary Artery Plaque Composition and Severity Relate to the Inflammasome in People With Treated Human Immunodeficiency VirusSamuel R Schnittman, Douglas W Kitch, Talia H Swartz, et al.
Pageof 43